HSIC vs ORMP
Henry Schein Inc (HSIC) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported HSIC revenue for 2024-12-28 was $12.67B. Net income was $398.0M. Revenue was up 2.7% from 2023-12-30 to 2024-12-28. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the HSIC and ORMP stock pages for the full models.
Not investment advice.